Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial

Mine Durusu Tanriover; Ozlem Altuntas Aydin; Rahmet Guner; Orhan Yildiz; Ilhami Celik; Hamdi Levent Doganay; Sukran Kose; Sila Akhan; Emin Halis Akalin; Zafer Sezer; Aykut Ozdarendeli; Serhat Unal; On Behalf Of The Turkovac Study Group

Vaccines (2022) - Comments
pubmed: 36366373 doi: 10.3390/vaccines10111865 issn: 2076-393x

Mine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, Orhan Yildiz, Ilhami Celik, Hamdi Levent Doganay, Sukran Kose, Sila Akhan, Emin Halis Akalin, Zafer Sezer, Aykut Ozdarendeli, Serhat Unal, On Behalf Of The Turkovac Study Group